Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Rises By 356.3%

Advanced Biomed Inc. (NASDAQ:ADVB) saw a large growth in short interest in June. As of June 15th, there was short interest totaling 8,876 shares, a growth of 356.3% from the May 31st total of 1,945 shares. Based on an average daily volume of 35,930 shares, the short-interest ratio is currently 0.2 days. Approximately 0.7% of the company’s shares are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Advanced Biomed Stock Performance

Advanced Biomed stock traded down $0.50 during trading hours on Friday, reaching $4.49. The company had a trading volume of 3,896 shares, compared to its average volume of 38,493. Advanced Biomed has a 12-month low of $3.61 and a 12-month high of $18.20. The stock has a 50-day simple moving average of $4.83. The stock has a market cap of $7.41 million, a price-to-earnings ratio of 0.93 and a beta of 0.68.

Advanced Biomed (NASDAQ:ADVB) last issued its earnings results on Friday, May 15th. The company reported ($0.38) EPS for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.